A Louisiana woman recently filed a Benicar lawsuit against Daiichi Sankyo over allegations she suffered serious side effects of Benicar.

Plaintiff Theresa S. claims that as a result of her Benicar use, she suffered from physical injury as well as economic loss. The physical injuries she was subjected to include sprue-like enteropathy (a serious gastrointestinal disorder that requires medical intervention), kidney failure, malnutrition, vomiting, abdominal pain, and others.

Theresa further alleges she was not adequately warned by Daiichi Sankyo of the potentially serious side effects of Benicar, such as sprue-like enteropathy, which led to her pain and suffering.

She has filed her Benicar lawsuit on 15 counts, including design defect, failure to warn, gross negligence, and fraudulent concealment and is seeking punitive damages for the physical, emotional, and financial harm she has suffered after taking the blood pressure medication

What is Benicar?

Olmesartan medoxomil drugs such as Benicar have become extremely popular, as well as widely distributed since their approval in 2002. In 2012 alone, approximately 1.9 million patients received a dispensed prescription for olmesartan-containing products from U.S. outpatient retail pharmacies.

On July 3, 2013, the FDA followed up their approval of Benicar with a Drug Safety Communication warning that the drug may cause several medical complications which can be quite severe, leading to chronic diarrhea, weight gain, and gastrointestinal issues such as sprue-like enteropathy.

Several studies have shown a possible connection between olmesartan medoxomil and several gastrointestinal problems, including a study published by Mayo Clinic researchers in 2012. Numerous case studies have been published in recent years.

Benicar Lawsuits

Benicar has recently been associated with multiple medical complications which have sparked a series of Benicar lawsuits for defectiveness and failure to adequately warn consumers of the potentially serious risks.

Many Benicar lawsuits have claimed that Daiichi Sankyo failed to perform necessary prolonged clinical trials to determine the effects of longer term cumulative exposure to olmesartan.

Plaintiffs in these Benicar lawsuits also claim that Daiichi Sankyo has, over the years, marketed their Benicar products in false or misleading ways which omit and/or minimize the potential risks associated with the drug.

This fraudulent behavior has, according to these Benicar lawsuits, led to consumers suffering from the side effects of Benicar that they were inadequately informed of.

Despite knowledge of the risks, the company allegedly continued to make claims as to the efficacy of their products, but did not conduct any clinical outcome trials that would prove this efficacy.

If you or someone you know has experienced side effects of Benicar such as sprue-like enteropathy, chronic diarrhea, or severe weight loss, you may be able to file a Benicar lawsuit.

The Benicar Lawsuit is Case No. 1:16-cv-00497-RBK-JS, in the U.S. District Court for the District of New Jersey Camden Vicinage.